{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-007115","form_type":"8-K","ticker":"ZSQR","cik":"0001759186","company_name":"Z Squared Inc.","filed_at":"2023-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.335343+00:00","generated_at":"2026-06-10T00:06:34.650688+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Coeptis Therapeutics issues 3M shares to two investors for $3M; $500k cash, $2.5M notes due 2024","bullets":["Issued 2.4M shares to Biofin Ventures for $2.4M ($400k cash + $2M promissory note due Aug 2024).","Issued 600k shares to AG Bio Life Capital I for $600k ($100k cash + $500k note due Aug 2024).","Notes bear 6% interest (18% on default), payable by Aug 30, 2024; investors may prepay.","If Biofin or AG sell shares before maturity, proceeds from sales must be contributed to the company.","Unregistered issuance dilutes existing shareholders by ~3M shares; only $500k received upfront."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-007115","json":"https://secwatch.observer/filing/0001683168-23-007115.json","markdown":"https://secwatch.observer/filing/0001683168-23-007115.md","text":"https://secwatch.observer/filing/0001683168-23-007115.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759186/000168316823007115/0001683168-23-007115-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759186/000168316823007115/coeptis_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:06:34.650688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}